Overview Impact of Pre-operative Bevacizumab on Complications After Resection of Colorectal Liver Metastases Status: Completed Trial end date: 2009-09-01 Target enrollment: Participant gender: Summary Hypothesis of the study: Neoadjuvant chemotherapy with Bevacizumab impairs postoperative outcome after resection of colorectal liver metastases. Details Lead Sponsor: University of ZurichTreatments: Bevacizumab